Financial News · Live Terminal

Page 430 of 545

Stephens Adjusts Price Target on Vulcan Materials to $340 From $330

Vulcan Materials Company (VMC) has an average rating of overweight and mean price target of $334.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $299.90, Change: $+3.82, Percent Change: +1.29%

Financial News · Live Terminal

Stephens Adjusts Price Target on Vulcan Materials to $340 From $330

Wedbush Cuts Price Target on Rithm Capital to $12.50 From $14, Keeps Outperform Rating

Accenture Invests in Customer Experience Agentic AI Platform Netomi

Barclays Adjusts Price Target on Vulcan Materials to $340 From $296

New Street Research Lowers Microsoft Price Target to $600 From $675, Maintains Buy Rating

Oppenheimer Adjusts Price Target on Amazon.com to $320 From $275, Maintains Outperform Rating

Corning Keeps Quarterly Dividend at $0.28 per Share, Payable June 29 to Holders of Record May 29

Zephirin Cuts Price Target on NOV to $17 From $18, Keeps Hold Rating, Medium Risk

Satellogic Signs $12 Million Deal for In-Orbit NewSat Satellite Delivery

AMETEK to Buy First Aviation Services

Orchestra BioMed Gets Second FDA Breakthrough Designation for Hypertension Therapy

Acadian Asset Management Shares Increase After Q1 Adjusted Earnings, Revenue Rise

Wedbush Lowers Price Target on Tenable Holdings to $27 From $32, Keeps Outperform Rating

UBS Adjusts Scotts Miracle-Gro Price Target to $70 From $67, Maintains Neutral Rating

UBS Adjusts Viavi Solutions Price Target to $60 From $25, Maintains Neutral Rating

Telomir Says US FDA Clears Investigational New Drug Application for Telomir-Zn to Treat Triple-Negative Breast Cancer

Oppenheimer Adjusts Price Target on Alphabet to $425 From $360, Maintains Outperform Rating

BNP Paribas Adjusts Price Target on Vulcan Materials to $300 From $291

NovoCure Shares Rise Following Q1 Financial Results

BNP Paribas Adjusts Price Target on PPG Industries to $116 From $115

Stephens Adjusts Price Target on Vulcan Materials to $340 From $330

Wedbush Cuts Price Target on Rithm Capital to $12.50 From $14, Keeps Outperform Rating

Accenture Invests in Customer Experience Agentic AI Platform Netomi

Barclays Adjusts Price Target on Vulcan Materials to $340 From $296

New Street Research Lowers Microsoft Price Target to $600 From $675, Maintains Buy Rating

Oppenheimer Adjusts Price Target on Amazon.com to $320 From $275, Maintains Outperform Rating

Corning Keeps Quarterly Dividend at $0.28 per Share, Payable June 29 to Holders of Record May 29

Zephirin Cuts Price Target on NOV to $17 From $18, Keeps Hold Rating, Medium Risk

Satellogic Signs $12 Million Deal for In-Orbit NewSat Satellite Delivery

AMETEK to Buy First Aviation Services

Orchestra BioMed Gets Second FDA Breakthrough Designation for Hypertension Therapy

Acadian Asset Management Shares Increase After Q1 Adjusted Earnings, Revenue Rise

Wedbush Lowers Price Target on Tenable Holdings to $27 From $32, Keeps Outperform Rating

UBS Adjusts Scotts Miracle-Gro Price Target to $70 From $67, Maintains Neutral Rating

UBS Adjusts Viavi Solutions Price Target to $60 From $25, Maintains Neutral Rating

Telomir Says US FDA Clears Investigational New Drug Application for Telomir-Zn to Treat Triple-Negative Breast Cancer

Oppenheimer Adjusts Price Target on Alphabet to $425 From $360, Maintains Outperform Rating

BNP Paribas Adjusts Price Target on Vulcan Materials to $300 From $291

NovoCure Shares Rise Following Q1 Financial Results

BNP Paribas Adjusts Price Target on PPG Industries to $116 From $115